Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Successful DNA Tagging of Leather at One of the World's Largest Tanneries

Business Wire November 12, 2019

Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors

Business Wire November 8, 2019

Applied DNA Sciences Announces 1-For-40 Reverse Stock Split

Business Wire October 31, 2019

Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials

Business Wire October 22, 2019

Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance

Business Wire October 16, 2019

Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA's Technology Published in Peer-Reviewed Journal

Business Wire October 4, 2019

Applied DNA Receives Extension from Nasdaq

Business Wire October 3, 2019

LineaRx's iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Prostate Cancer Trial

Business Wire October 1, 2019

Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season

Business Wire September 24, 2019

LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction

Business Wire September 19, 2019

Applied DNA Extends Textiles Business to Include Global Down and Feather Supply Chain in Partnership with Industry Leader Navarpluma

Business Wire September 5, 2019

Applied DNA Reports Fiscal Third Quarter 2019 Financial Results

Business Wire August 13, 2019

Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx

Business Wire August 12, 2019

LineaRx Acquires Assets and Intellectual Property of Vitatex

Business Wire August 8, 2019

Applied DNA Signs Master Services Agreement with Schreiner Group to Deliver SigNature® DNA Labels to Protect Pharmaceutical Supply Chains

Business Wire August 7, 2019

Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET

Business Wire August 6, 2019

Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement

Business Wire August 5, 2019

Applied DNA Raises $1.5 Million In Secured Convertible Notes

Business Wire July 17, 2019

Applied DNA Signs 5-Year Agreement with Iconic Writing Instrument Specialist Montblanc-Simplo GMBH to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients

Business Wire July 2, 2019

LineaRx Receives Multiple Purchase Orders for Linear DNA for Use in Therapeutic Development

Business Wire July 1, 2019